← All trials
NCT05419908
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 21, 2015
- Primary completion
- Sep 21, 2016
- Completion date
- Oct 6, 2016
- First posted
- Jun 15, 2022
- Last posted
- Sep 9, 2022
- Enrollment
- 87
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Ogeda S.A.Lead sponsor
- Ogeda S.A.Study director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.